(RTTNews) - Janssen-Cilag International NV, a Johnson & Johnson company, announced the submission of the Marketing Authorisation Application to the European Medicines Agency seeking first approval of ...
(RTTNews) - Canadian fintech company Nuvei Corp. (NVEI, NVEI.TO) announced Tuesday that it has secured an in-principle approval for a Retail Services Category II License from the Central Bank of the ...
(RTTNews) - Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the Phase 3 BREAKWATER study of BRAFTOVI (encorafenib) ...
(RTTNews) - GE Aerospace (GE) announced plans to invest more than $1 billion over five years in its Maintenance, Repair and Overhaul and component repair facilities worldwide. GE Aerospace regional ...
(RTTNews) - Jones Lang LaSalle Inc. (JLL), Wednesday stated that the company has raised over $1.2 billion in construction financing to develop four hyperscale powered shell campuses across Northern ...
(RTTNews) - BAE Systems plc (BA.L) on Monday announced that the company has received a contract from the U.S. Defense Advanced Research Projects Agency as part of the High Operational Temperature ...
(RTTNews) - Crown Holdings, Inc. (CCK) announced Wednesday it has completed the strategic divestiture of the approximate 20% stake it retained in its Switzerland-based European Tinplate business ...
(RTTNews) - Marin Software Inc. (MRIN) has issued a response to the recent landmark antitrust ruling against Google by the United States District Court for the District of Columbia. The Court found ...
(RTTNews) - Thursday, mining company Rio Tinto Group (RIO, RTPPF.PK), and aluminum company Norsk Hydro ASA announced the decision to invest nearly $45 million to identify and evaluate available carbon ...
AbbVie Submits BLA To FDA For Telisotuzumab Vedotin In Previously Treated Non-Small Cell Lung Cancer
(RTTNews) - AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated approval of telisotuzumab vedotin (Teliso-V) in adult ...
(RTTNews) - Johnson & Johnson (JNJ) announced that Health Canada has issued a Notice of Compliance for RYBREVANT (amivantamab for injection) in combination with carboplatin and pemetrexed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results